Dr. Pitt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 East Medical Center Dr
3rd Floor Cardiovascular Center
Ann Arbor, MI 48109Phone+1 888-287-1082
Education & Training
- Johns Hopkins UniversityFellowship, Cardiovascular Disease, 1966 - 1966
- Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1960 - 1963
- Mount Sinai Beth Israel HospitalInternship, Transitional Year, 1959 - 1960
- University of Basel Faculty of MedicineClass of 1959
Certifications & Licensure
- MI State Medical License 1978 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I) Start of enrollment: 2008 Mar 01
- The Impact of Pomegranate Extract on Chronic Cardiomyopathy Complicated by Renal Insufficiency (ImPrOVE): a Pilot Study Start of enrollment: 2010 Jul 01
Publications & Presentations
PubMed
- 964 citationsSotagliflozin in Patients with Diabetes and Recent Worsening Heart FailureDeepak L. Bhatt, Michael Szarek, P. Gabriel Steg, Christopher P. Cannon, Lawrence A. Leiter
The New England Journal of Medicine. 2021-01-14 - 22 citationsPredictors of sudden cardiac death in high-risk patients following a myocardial infarctionKieran F. Docherty, João Pedro Ferreira, Abhinav Sharma, Nicolas Girerd, John Gregson
European Journal of Heart Failure. 2020-01-16 - 6074 citationsThe effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.Bertram Pitt, Faiez Zannad, Willem J. Remme, Robert J. Cody, Alain Castaigne
The New England Journal of Medicine. 1999-09-02
Journal Articles
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart FailureDeepak L Bhatt, Darren K Mcguire, Jeffrey M Testani, Pablo Lapuerta, Bertram Pitt, The New England Journal of Medicine
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 DiabetesBertram Pitt, MD, The New England Journal of Medicine
- Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure with Preserved, Mid-Range, and Reduced Ejection FractionBertram Pitt, JACC: Cardiovascular Imaging
- Join now to see all
Authored Content
- Oxford University Press Has Registered This DOI Pre-PublicationOctober 2018
- Declining Risk of Sudden Death in Heart FailureJuly 2017
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure — NEJMSeptember 1999
Press Mentions
- 25th Anniversary of a Landmark Study in Coronary RevascularizationOctober 30th, 2024
- Topline Finerenone Results Point to Advance in Heart FailureAugust 28th, 2024
- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2022 Earnings Call TranscriptMarch 6th, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: